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Abstract
Investigation using stem cells started in 1960 with the discovery of the first viable source of these cells: bone marrow. Several 
studies detailed their role in tissue renewal and regeneration after damage, as well as its characterization as a heterogeneous group of 
undifferentiated cells called ‘clonogenic’ (defined by their self-renewal capacity and differentiation into mature cells). 
Nowadays, these cells have gained popularity as a therapeutic alternative for many diseases such as diabetes, congenital abnormalities, 
nervous tissue injuries, Parkinson, pulpal exposure, periodontal defects, loss of teeth, Alzheimer and other degenerative disorders.
Studies have also helped to identify five populations of stem cells of dental origin (DPSCs, SHEDs, DFPCs, SCAPs and PDLCs). 
Additional research into stem cell therapy is still required, however, the use of these cells in tissue engineering is considered obligatory 
as it has the potential to provide new tools for regenerative medicine via the combined use of biomaterials and biological agents. It 
offers highly desirable biomimetic principles and, as stated by ‘conservation practitioners’, regenerative medicine is the most promising 
way for the development of personalized medicine.
For these reasons, results on stem cell research have triggered much debate and high expectations in the field of tissue engineering.
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Introduction
Stem cells studies started fifty years ago, when researchers 
found out that the bone marrow is a viable source of these cells. 
Nowadays, due to their properties, stem cell implementation in 
Tissue Engineering looks promising [1].
Tissue Engineering is an interdisciplinary field that combines 
engineering, materials and biological sciences backgrounds 
towards the development of therapeutic strategies that restore, 
keep, substitute or improve biological functions. Promoting 
this knowledge potentiates the development of new treatment 
possibilities, in most biomedical areas, including Dental Medicine 
[2].
Stem cells have the capacity of division, giving rise to an 
identical cell able to generate different tissue types [3]. The 
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pluripotent nature of these cells is the basic concept of regenerative 
therapies, since they can differentiate into cells belonging to all 
types of tissues of the body [4]. The big hope is that stem cells 
produced in big amounts and later transferred, give rise to new 
cells that will be used to replace lost or damaged tissues. This 
tissue regeneration capacity is the focus of the emerging field of 
personalized medicine. The main disadvantages of this are ethical 
dilemmas (depending on the origin of the cells), the carcinogenic 
potential and the risk of immunological rejection [5].
Recent studies showed the presence of stem cells in dental 
tissues, with an expansive differentiation potential concerning 
mesodermal and ectodermal lines [6-8]. These cells can be 
collected from dental pulp, periodontal ligament, apical papilla and 
precursor cells of dental follicle [6-12].
All these exciting discoveries put Dental Medicine in the 
frontline of a potential revolution on therapeutic options. The 
dental doctor plays an important role in the recovery and use of 
dental stem cells (obtained from deciduous and permanent teeth) 
as well as in the execution of regenerative medical therapies.
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To benefit from therapies able to save lives through the use of 
stem cells, it is essential to know all the surroundings, advantages 
and limitations. 
Dental Stem Cells
Post-natal stem cells can have different origins, including 
teeth [13]. The first dental stem cell described in the literature 
was isolated from dental pulp and was called Dental Pulp Stem 
Cell (DPSC) [6]. After that, three other groups of stem cells were 
isolated and characterized: Stem Cells from Human Exfoliated 
Deciduous Teeth (SHEDs) [7], Periodontal Ligament Stem 
Cells (PDLSCs) [8] and Stem Cells from the Apical Papilla 
(SCAPs) [12]. More recently, were identified four more groups: 
Dental Follicle Precursor Cells (DFPCs) [11], Alveolar Bone-
Derived Mesenchymal Stem Cells (ABMSCs) [14], Tooth Germ 
Progenitor Cells (TGPCs) [15] and Gingival Mesenchymal Stem 
Cells (GMSCs) [16].
Published data show that DPSCs, SHEDs, DFPCs, PDLCs, 
ABMSCs, TGPCs and GMSCs  fulfil all the requirements to be 
considered stem cells: adhere to plastic; express the cellular markers 
CD73, CD90 and CD105; and have the capacity to differentiate 
into osteoblasts, adipocytes and chondrocytes both in vitro and in 
vivo. SCAPs, although they present mesenchymal markers, it was 
still not possible to show chondrogenic differentiation [9].
Comparative Odontogenic Capacity Between Bone 
Marrow And Dental Pulp Stem Cells
BMMSCs are in close proximity to hematopoietic stem cells 
and were initially called “bone marrow stromal cells” [17]. Their 
ability to form clonogenic colonies is similar to hematopoietic 
stem cells, and explains their self-renewal capacity. These cells 
can be isolated from suspensions obtained by aspiration of the 
bone marrow [18] and present migration capacity [19,20]. 
Morphologically, they present a considerable heterogeneity in 
terms of size, morphology, histochemistry, proliferation, cellular 
maturity and development potential [6,21-23]. They are able to 
differentiate into osteoblasts, chondrocytes or retinal cells, which 
means that they have are able to differentiate into cells of at least 
two different germ layers [18,24,25]. Some studies have reported 
the possibility of myogenic differentiation [26-29].
Due to certain difficulties in obtaining BMMSCs (including 
pain, morbidity and low numbers of cells in each crop), alternative 
sources of stem cells have been sought [9]. Recently, dental cell 
therapies have been discussed through the combination of non-
dental mesenchymal stem cells and dental stem cells [30-32]. 
Following the accomplishment of numerous studies in this scope, 
it was concluded that BMMSCs can be reprogrammed in order to 
constitute a valid possibility for the development of dental tissue 
engineering [33]. These data are promising, but the use of dental 
stem cells - such as DPSCs - seems more feasible since these cells 
are closely related to mature dental tissues [34].
DPSCs and BMMSCs, due to their ability to differentiate into 
multiple mesenchymal cell lines, are excellent candidates for tissue 
engineering with the aim of reconstructing the entire dental element 
and bone tissue respectively [6,35-38]. Previous studies have 
shown that dentinogenesis and osteogenesis mediated by DPSCs 
and BMMSCs occur through distinct mechanisms, promoting the 
differentiated organization of different dental elements and bone 
[37]. Studies have shown that both DPSCs and BMMSCs can 
be used to generate dental structures under appropriate conditions 
[6,31,33,35,37,39]. Knowledge is limited concerning differences 
in odontogenesis when mediated by different cell groups, although 
DPSCs appear to be more competent than BMMSCs in this 
function [40].
Dental Medicine Applications Of Stem Cells
Losing teeth is a common disease that occurs frequently in 
elderly populations, affecting negatively the masticatory efficiency, 
speech, aesthetics and self-esteem. According with data from World 
Health Organization, dental caries is present in most countries 
all over the world (with 100% incidence in certain populations), 
serious periodontal diseases affect 5-20% of adult populations and 
incidence of total edentulousness has been estimated between 7% 
and 69% [41].
Therapeutic strategies used so far are mainly centered in 
artificial material or non-biological implants that might reduce 
life quality, due to the limited physiological functions and, in 
some cases, can even lead to immunological rejection [42]. The 
development of a biomimetic technique that allows the formation 
of substitution teeth, constitutes a highly desirable approach 
for permanent replacement of teeth in situ [43]. This strategy 
was used by Modino and Sharpe [43] where aggregates of stem 
cells of mice were inserted in the mandibular primordium. These 
researchers performed in vitro and in vivo assays in adult mice and 
observed normal sized teeth formation that were connected to the 
underlying bone. This study shows that developing tooth germs 
might be successfully implanted into the gingiva of patients.
In order to develop cellular therapies based on regenerative 
medicine, it is essential to understand: the self-renewal mechanisms 
that allow the in vitro regulation of adult stem cells growth, 
giving rise to sufficient number of cells for different applications 
[40,44,45]; the regulation of stem cells during differentiation 
and production of a specific tissue [46]; the interactions between 
stem cells and the immunological system [47]; how to perform 
monetarization of the transformed and expanded stem cells [48].
Periodontal Regeneration
Periodont is a group of specialized tissues that surrounds and 
supports teeth in order to keep them in the jaw. Periodontitis is an 
inflammatory disease that affects periodont and results in irreversible 
loss of teeth insertion in the connective tissue and supporting 
alveolar bone. Procedures to achieve periodontal regeneration 
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have included root surface conditioning, bone graft placement, 
guided tissue regeneration and growth factor application. Sander 
and Karring [49] used the guided tissue regeneration procedure 
for healing of periodontal lesions in monkeys. However, current 
regenerative procedures have limitations in attaining complete and 
predicable regeneration, especially in advanced periodontal defects 
[49].
The challenge for tissue engineering, in this particular case, 
consists on the use of different populations of dental stem cells in 
order to replicate the key events of periodontal development and 
promote sequential regeneration of periodont [50].
Four factors must be respected in order to promote a successful 
periodontal regeneration: it is essential to check the epithelial 
sealing to avoid migration of epithelial cells to periodontal defects; 
new acellular cementum must be regenerated at the root surface; 
height of alveolar bone must be  re-established and new Sharpey 
fibers must be inserted in the newly formed cementum [51]. A 
successful outcome of periodontal tissue engineering also requires 
the following essential factors: an adequate supply of appropriate 
progenitor cells with the capacity to differentiate into the 
required mature tissue-forming phenotypes, including osteoblasts, 
cementoblasts and fibroblasts; the appropriate signals to modulate 
cellular differentiation and tissue neogenesis; and a conductive 
three-dimensional extracellular matrix scaffold to support and 
facilitate these processes [52]. Additionally, angiogenic signals, 
promoting new vascular networks, are essential to provide the 
nutritional base for tissue growth and homeostasis. Furthermore, 
appropriate mechanical loading is required for the development of 
highly organized, functional periodontal ligament fibers. Finally, 
as periodontal defect sites are accompanied by a microbial load, 
strategies to control infection and host response are required for 
optimum periodontal regeneration [53].
Although research in this field usually involves the use of 
non-dental stem cells, regarding their differentiation potential, 
PDLSCs constitute an ideal candidate for periodontal tissue 
engineering [54]. One approach to periodontal regeneration 
involves incorporation of progenitor cells in a periodontal defect 
[55]. Published data indicate that these cells, when expanded in vivo 
and transplanted into mice (using hydroxyapatite phosphate and 
tricalcium phosphate) are able to regenerate fibers of periodontal 
ligament and a layer similar to acellular cementum [8, 56]. The 
main doubt related with this technique concerns the maintenance 
of integrity and function of regenerated periodont [57]. 
Although direct application of PDLSCs looks promising, it is 
still in its stage of infancy, and more work is needed in this area to 
validate results. Stem cell assistance in periodontal regeneration 
technique could overcome the limitations and concerns of ex vivo 
cell culture techniques as they are costly and sensitive and there is 
chance of loss of stem cells during cell passage, genetic alteration 
and tumorigenic potential [58]. The autologous stem cell assistance 
in periodontal regeneration technique has emerged as a constructive 
avenue in the treatment of periodontal osseous defects. In a recent 
study, Vandana et al. [59] harvested  autologous PDLSCs for 
regeneration of intraosseous periodontal defects, bypassing ex vivo 
culture. These authors obtained successful clinical and radiographic 
parameters like gain of clinical attachment, decreased probing 
pocket depth and satisfactory defect fill of intraosseous defects 
when evaluated during a one-year period [59].
At present, the limitations are the uncertainty on the number 
and viability of cells transplanted immediately after scraping 
the tissues from the root surfaces of extracted teeth. For now, 
lack of histological evidence and in vitro analysis of stem cell 
characterization and osteogenic potential are some important 
shortcomings [59].
Pulp Regeneration
Dental pulp regeneration would change current practice of 
replacing infected pulp by inorganic materials (devitalization).
According with the characteristics of cell sources, if the goal 
is to regenerate dental pulp the best dental cellular sources are 
SHEDs and DPSCs [60]. The protocol established by Yan et al. 
[42] for this purpose consists on isolation of DPSCs and SCAPs 
from human third molars, cover these cells with a matrix of 
copolymer (poly-DL-lactide and glicolide) and insert this mixture 
into the canal space previously emptied [42]. A study performed 
in mice to evaluate this procedure allowed to see that, after 3-4 
months, the root canal had been completely filled by pulp tissue 
with well-established vascularization and a continuous layer of 
tissue similar to mineralized dentine had been deposited over the 
existent dental walls in the canal [42].
Dentin Regeneration
Regenerative property of the pulp-dentin complex mainly 
depends on the formation of tertiary dentin (reparative dentin). 
DPSCs are the better type of stem cells to be used on 
tertiary dentinogenesis [6,61-63]. They migrate, proliferate and 
differentiate into odontoblasts, which then synthesize matrix to 
form the tertiary dentin at the damaged sites [64].
There are two different approaches implemented in dentin 
regeneration by the use of tissue engineering techniques. The first 
approach includes a device which can be used as a filling material 
into a deep cavity of tooth with partial layer of dentin on top of the 
pulp. In this process, they used some growth factors or molecules 
that can form reparative dentin [65,66]. The second approach is to 
put scaffold on open pulp along with odontoblast-like cells to grow 
on it, and these cells will synthesize reparative dentin [67].
DPSCs have been cultured on a variety of scaffolds to engineer 
dentin tissues. There are several examples in literature on the use 
of these strategies as is the case of Wang et al. [63] that performed 
in vitro and in vivo (in rat models) experiments with DPSCs cells 
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overexpressing CCN3. This study showed that CCN3 can promote 
dentinogenesis by coordinating proliferation and odontoblastic 
differentiation of DPSCs. This is a promising therapeutic strategy 
in dentin regeneration.
Another example is work of Chiang et al. [65] who used an 
inorganic degradable biomaterial that acts as a growth factor 
reservoir to promote reparative dentinogenesis in HDPC cells 
and in rat animal models. In this study, scientists observed the 
formation of dentin-pulp tissue, concluding that this strategy has a 
high potential to form the reparative dentinogenesis in vivo [ 65].
Moreover, Zhang et al. [66] demonstrated that the vascular 
endothelial growth factor  promotes reparative dentin formation 
both in vitro and in vivo. Data from the in vivo assays (rat models) 
indicated that this growth factor enhanced pulp cell proliferation 
and neovascularization, and markedly increased formation of 
reparative dentin in dental pulp.
However, the signalling pathways underlying the regulation of 
DPSCs in dentin regeneration remains largely unknown, limiting 
their effective application in dentin tissue engineering [68].
 Apicogenesis and Apicification
Closing of the root apice of a permanent tooth occurs until 3 
years after tooth eruption. The presence of irreversible pulp damage 
in an immature permanent tooth represents a clinical challenge 
and this justifies the appearance of the concepts of Apicogenesis 
and Apicification [69]. 
Apicogenesis is a root complementation therapy performed 
in teeth with pulp vitality and consists in the removal of infected 
coronal pulp, maintenance of vital root pulp and its protection with 
biocompatible material. Calcium hydroxide and mineral trioxide 
aggregate have been the chosen materials, but, so far, there is no 
ideal material since none of them is able to stimulate pulp tissue 
regeneration [70,71]. Apicification is a therapy based on closure 
induction of apical foramen in teeth having pulp necrosis and 
consists in deposition of a hard tissue barrier in the apice. This last 
technique is more desirable and ideally uses stem cells [69].
To perform apicification with stem cells, these cells have to be 
grown and expanded in vitro or in vivo to be used later on. If the 
expansion is done in vitro, cells are implanted and must adhere to 
the walls of the root canal (previously disinfected). The implanted 
tissue lacks the needed vascular supply and previous data describe 
that it is technically difficult to introduce the regenerated pulp 
tissue without damaging cells. The in vivo approach overcomes 
some problems concerning the re-introduction of cells and 
one of the possible techniques consists in growing SHEDs and 
endothelial cells in biodegradable matrixes and apply the substrate 
in human teeth implanted in immune-compromised mice. This was 
performed by Cordeiro et al. [72] and the obtained data showed 
that SHEDs differentiated in vivo (rat model) into odontoblast-
like cells as well as into endothelial-like cells.
Regeneration of Dental Element
Nowadays clinical practice indicates tooth implants as the most 
advanced technique for tooth substitution. It is known that this 
approach presents several disadvantages, like requiring a minimal 
amount of existing bone and the absence of periodontal ligament 
that sustains masticatory forces. Due to these problems, scientists 
started to think about bio-tooth. It consists of a biological tooth 
that can be re-integrated in the jaw and execute normal functions 
of a natural tooth (including the regenerative capacity when there 
is damage). Several studies have shown that the bio-tooth can be 
rebuild from dental cells involved or not in matrixes, from dental 
pre/postnatal cells and even from non-dental cells [42].
The minimal requirement for an adequate biological 
substitution is the formation of minimal components necessary 
for the development of a functional tooth (that includes roots, 
periodontal ligament, nervous and blood supply) [57]. If the goal is 
to regenerate tooth root it is better to use a combination of SCAPs 
and PDLSCs [12]. Coronal replacement constitutes the lower 
source of problems because, although essential, synthetic tooth 
coronas are aesthetically and functionally compatible [57].
The main challenges are: to identify non-embryonic cell sources 
that show the same properties of dental germinative cells and to 
develop culture conditions that allow expansion and maintenance 
of the potential of these cells. All these becomes more challenging 
when tooth development requires two types of cells, epithelial and 
mesenchymal cells [73-75]. By fulfilling these criteria, it becomes 
possible to obtain a three-dimensional structure that is functional 
and differentiated, capable of avoiding transplant rejection [76].
As teeth are formed by the cooperation of two different tissues, 
tooth reconstruction requires the interaction between them [77]. 
The odontogenic potential present in the tooth epithelium, when 
combined with mesenchymal cells is responsible for morphogenesis 
and cyto-differentiation – leading to tooth formation [78-81]. 
This is only possible due to the plasticity characteristic of some 
adult tissues. Molecular mechanisms involved in the interaction 
between epithelium and mesenchyme involve diffusible proteins 
like bone morphogenic proteins, fibroblast growth factors and 
tumor necrosis factor [76].
After epithelial induction of mesenchyme, this one becomes an 
inductive tissue and retrieves the induction to the non-inductive 
epithelium. Tooth regeneration can then occur through the use of 
epithelial or mesenchymal cells that induce tooth development into 
the other type of cells [57]. That cellular interaction leads to the 
formation of a tooth primordium that is chirurgically transplanted. 
The formed tooth must show certain characteristics: functional 
odontoblasts, ameloblasts, pulp, cuspid formation and also roots 
and periodontal ligament [82].
Although in vitro cell culture techniques are being progressively 
developed and improved, it is still needed to find stem cell 
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populations that can replace embryonic tooth epithelium and tooth 
mesenchyme. DPSCs have been used on regeneration of partial 
tooth structures, however, due to their in vitro limited expansion, 
it was still not possible to promote regeneration of a tooth that is 
morphologically and functionally competent [6].
Complete tooth regeneration still faces several obstacles: 
abnormal establishment of tooth size, failure in root formation and 
absence of functional occlusion [9]. In order to overcome these 
problems, Sonoyama et al. [12] showed that the best would be to 
create a bio-root and complete the tooth by using a tooth corona. 
Still, literature reports that frequently there is a change in the 
bio-root dentin that leads to two thirds decrease in mechanical 
resistance [9].
Replacement of missing teeth with “natural” tissue engineered 
teeth in humans is some way off and indeed may prove too difficult, 
irreproducible or expensive. However, there is a real possibility that 
this will be achievable and, although there are no guarantees, what 
we learn along the way will be invaluable in our understanding of 
tooth development and stem cell biology [16].
Clearly, recent recognitions of dental stem cells and their role 
in making a bio-tooth provide a substantial basis upon which we 
can begin to explore their therapeutic potential at the preclinical 
level. However, making a bio-tooth with masticatory function 
and supportive tissues from dental stem cells may be much more 
complicated than expected. Key techniques must be developed 
to reproduce the highly specialized arrangements of dental 
stem cells that constitute a bio-tooth. Several issues involving in 
the making of a stem cell-mediated bio-tooth must be solved, 
including identification and ‘stemness’ maintenance of stem cells, 
dental morphogenesis, tooth type determination, odontogenic 
signal cascades, odontogenic epithelium availability, controllable 
bio-tooth growth and eruption, pulp revascularization and neural 
regeneration, and host-graft  immune rejection in the jaws [70, 83-
85]. Although there are many technical barriers to overcome, stem 
cell-based approaches to tooth reconstruction will, of necessity, 
provide an unpredictable applicative opportunity to treat tooth loss 
and other dental diseases [86].
Craniofacial Bone Regeneration
Congenital craniofacial  deformities or caused by trauma are big 
challenges for clinicians, since commonly used surgeries present limited 
therapeutic outcomes. For this reason, new strategies based on the use of 
stem cells have been developed with the purpose of bone repair.
Several studies have been done where different types of stem 
cells were used for cranium-facial bone regeneration. A good 
example is a study of Alhadlaq and Mao [87] where a human-
shaped mandibular condyle was tissue-engineered from rat 
mesenchymal stem cells encapsulated in a biocompatible polymer. 
These authors observed de novo formation of mandibular condyles, 
eight weeks after in vivo implantation [87].
Adipose derived stem cells are an alternative cell source and 
have been successfully applied to scaffolds, leading to de novo 
formation of bone in subcutaneous tissue, calvarial defects, and 
critical sized bone defects in murine models [88-90]. This strategy 
has been applied to human calvarial bone defects [83,91].
Other studies have used dental pulp stem cells for 
oromaxillofacial bone repair. d’Aquino et al. [92] applied this type 
of stem cells on collagen sponge scaffolds and showed that it can 
be an effective therapeutic strategy for bone defects restoration 
[92]. In another study, d’Aquino et al. [93] have shown that several 
cytotypes can be obtained from dental pulp stem cells owing to 
their multipotency and that transplantation of new-formed bone 
tissue obtained from dental pulp stem cells leads to the formation of 
vascularized adult bone and integration between the graft and the 
surrounding host blood supply [93]. This study has demonstrated 
that: DPSCs can be used for human mandible bone defect repair, 
the use of DPSCs on appropriate absorbable scaffolds produces 
and efficient biocomplex and collagen sponges can be considered 
an optimal support for stem cells in cell-guided regeneration [93]. 
That have given evidence that DPSCs can be used in a low-risk 
and effective therapeutic strategy for the repair of bone defects. 
Despite the optimal results, the flaws of this study reside mainly 
in the small number of patients enrolled. Longer patient follow-up 
would ascertain the lifespan of the regenerated bone [94].
Recent work of Chamieh et al. [95] focused on therapies using 
mesenchymal  dental pulp stem  cell seeded scaffolds for several 
areas of regenerative medicine, like cranio-maxillofacial surgery. 
The collagen scaffolds with these stem cells were able to increase 
osteogenic differentiation of these stem cells in a rat model having 
a calvarial defect contributing to the bone healing process [95].
Moreover, Maruyama et al. [96] showed that suture mesenchymal 
stem cells can be used for injury repair and skeletal regeneration. 
This work has identified those cells as skeletal  stem  cells  with 
innate capacities to replace the damaged skeleton by the use of a 
cell-based therapy [96].
These studies suggest that optimal cell types and local factors 
are essential to make possible human application of these strategies.
Standardization Of SHEDs Collection, Isolation And 
Conservation
Success in collecting, isolating and conserving SHEDs is 
achieved when harvesting is done at the optimum developmental 
stage and stored safely until needed. Needless to say, this often 
means storing the cells for decades, which significantly increases 
the cost and difficulty of the technique [97]. To this end, 
among all sources of existing dental stem cells, SHEDs are the 
best alternative. Huang et al. [98] in vitro study concludes that: 
different isolation methods give rise to different populations or 
lineages of pulp cells during in vitro passage, direct contact of 
pulp cells with mechanically and chemically treated dentin may 
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promote pulp cells to differentiate into odontoblasts with processes 
extending into dentinal tubules and collagen matrix alone may not 
be a suitable scaffold for pulp tissue engineering [98]. The protocol 
for the isolation and conservation of these cells is presented below 
[97].
Dental Collection
Since the best alternative is the collection of stem cells from 
deciduous teeth and, in this case, the donor still does not have 
decision-making power, it must come from the parents. It is 
therefore essential to inform them that they should store their teeth 
in a sterile saline solution when removing the tooth and inform 
the “tooth bank”. The tooth must have reddish dental pulp (which 
demonstrates that it has received blood flow until removal), which 
is indicative of cell viability. If the pulp is greyish, it is likely that 
the blood flow to the pulp has been compromised and therefore 
stem cells are in necrosis and therefore no longer viable. Teeth 
exhibiting class III or IV mobility often have decreased blood 
supply and are not candidates for collection of stem cells. For these 
reasons, it is preferable to extract deciduous teeth than to expect 
them to fall naturally. Moreover, stem cells should not be collected 
from apical abscesses, tumors or cysts. The dentist should inspect 
the extracted tooth to confirm the presence of healthy pulp tissue 
and transfer it into a hypotonic phosphate buffered saline flask, 
which provides nutrients and helps preventing tissue dehydration 
during transport. Viability of stem cells is dependent on time and 
transport temperature. The period of time from collection to arrival 
to the storage and processing unit should not exceed 40 hours. The 
tooth should be placed in the vial at room temperature in order 
to induce hypothermia which is desirable for transport - this 
procedure is described as support.
Isolation of Stem Cells
When the stem cell bank receives the tooth, the following 
protocol is initiated:
• Cleaning the tooth surface by repeated washing (three times) 
with Ca2+ and Mg2+ (PBSA) Dulbecco’s phosphate buffered 
saline.
• Disinfection with Povidone Iodine and re-washing with 
PBSA.
• Separation of pulp tissue from the pulp chamber using small 
forceps or sterilized dental excavator.
• The tissue collected from the dental pulp is placed in a sterile 
petri dish, which has been washed at least three times with 
PBSA. The tissue is then digested with collagenase type I 
and dispenses for 1 hour at 37°C. Trypsin-EDTA may also 
be used.
• Isolated cells are passed through a 70μm filter to obtain single 
cell suspensions.
• Cells are cultured in a culture medium suitable for 
mesenchymal stem cells consisting of 2mM glutamine 
supplemented with 15% fetal bovine serum (FBS), 0.1mM 
L-ascorbic acid phosphate, 100 U/mL Penicillin, 100 μg/
mL streptomycin at 37°C and 5% CO2 gas. Usually, isolated 
colonies are visible after 24 hours.
• Different cell lines, such as odontogenic, adipogenic and 
neural, can be obtained according to the changes made to 
the culture medium. After verification of the success of the 
process, cell viability is confirmed to the donor’s parents.
Storage of Stem Cells
To store dental stem cells, it is possible to use Cryopreservation 
(process of preserving complete cells or tissues by lowering the 
temperature to below zero) or Magnetic Freezing (this technology 
uses a weak magnetic field that reduces 6-7ºC the solidification 
point of the body). Storage is proceeded in Tooth Baking. Needless 
to say that this means potentially storing for decades, and the 
cost and technical difficulty of doing this properly makes stem 
cell therapy using one’s own cells a still uncertain bet. Nowadays, 
tooth banking is still not very popular but the trend is catching up 
mainly in developed countries, like USA, UK, Thailand, Japan and 
Norway).
Potential Limitations And Challenges
Stem cell therapy represents a fascinating new approach for the 
repair of defective tissues or functions through the transplantation 
of live cells. However, multiple key parameters need to be 
optimized through clinical research such as the required stem cell 
density and availability, as well as appropriate strategies, for their 
use. Nowadays, biotechnology companies working on stem cell 
therapy are focused on developing and commercializing human 
stem cell technology in the emerging field of regenerative medicine 
to treat degeneration of major organ systems. There are dozens of 
companies that are trying to develop cell therapy, however there are 
lots of questions… Can companies produce all the required cells 
under current good manufacturing practices? How much does it 
cost to produce these cells and how high are the profit margins? 
Will anybody be able to afford the therapy [50]?
Another issue is the availability of the cells over time, that 
is, DPSCs or SHEDs are not available throughout a patient’s 
lifetime. Even though DSC banking may constitute a potential 
solution by cryopreserving them for future use, such a possibility is 
not only time-consuming and costly but limits their use in clinical 
applications [99].
Culture conditions, dose of cell infusion, number of infusions, 
and route of cell delivery need to be optimized. Appropriate 
double-blind randomized clinical trials still need to be performed 
to confirm the true regenerative power of these stem cells. The 
immune rejection is a major risk for cell transplantation, so 
biosecurity is a crucial point for cell therapy, requiring control of 
cell transformation and a protocol for cellular biobanking. The risk 
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of transmission of bacterial, viral, and fungal or prion pathogens 
may lead to life-threatening reactions [100]. Manufacturing of 
cell-based medicinal products inevitably does not include terminal 
sterilization, purification, viral removal, and inactivation. Hence, 
viral and microbial safety is a pivotal risk factor associated with the 
use of non-autologous cells including stem cells. Further research 
and understanding of the stem cells physiology may enhance 
development of novel and more competent therapeutic approaches 
and will help in fulfilling the huge impact that stem cell therapy 
will have for future healthcare [68].
Finally, it is important to say that most of studies are made 
in animal species. Cellular characteristics between species (for 
instance, human vs rodent) appear to be significantly different 
when they are cultured in vitro. Rodent cells show high viability, 
stable growth and proliferation, and toughness to stimulation 
during culture (artificial conditions). Thus, it is easier to isolate and 
establish primary cells or new cell lines from harvested rodent tissue 
than from human samples. However, stem cell research, especially 
in regenerative medicine, may require culture experiments using 
human sources. Hence, data on human stem cell characteristics is 
necessary for safe and reliable clinical application. Further studies 
using human cells and the resulting accumulation of knowledge 
will lead us to the development of innovative cell-based therapy 
for dental and systemic diseases. Given the immense amount of 
funding provided for stem cell research, research and development 
will undoubtedly advance in the future, and patents and research 
reports will continue to appear [101].
Conclusion
These last years a growing enthusiasm by the biomedical 
community is felt concerning stem cell therapies. These are based 
on the theory that when healthy stem cells are injected into 
patients, they automatically go to damaged tissues, stimulating 
their regeneration [84].
It is possible to conclude that stem cells of dental origin 
constitute a viable alternative to regeneration. Cellular Therapy can 
benefit from this new source of cells, since they are self-renewal, 
multipotent, with simple isolation and able to give rise to different 
cell lines [85,102].
Advances in adult stem cell biology show up like an impulse 
for the clinical applications. Developments in isolation and 
understanding of tooth stem cells together with the development 
of biomaterial sciences, led to consider these cells a powerful tool 
for Regenerative Dental Medicine (capacity of tooth cells to replace 
other tooth cells) and, later on, for general medicine (capacity 
of tooth cells to differentiate into non-dental cells). In terms of 
applications in Dental Medicine, it is noticeable the differentiation 
capacity of these cells into diverse tooth components, allowing 
individual or generalized regeneration of the tooth [103].
The minimal intervention required to obtain these cells, 
absence of autoimmune rejection and repair efficacy (according 
with an analysis cost-benefit), constitute the main advantages to 
support therapies in the near future [60]. Although the advantages 
are numerous, certain negative aspects must be considered. 
It is required to evaluate the probability of development of a 
carcinogenic process. Cost associated with the therapeutic use of 
these cells is still very high, however history has shown that most 
revolutionary technologies become accessible when they start to be 
popular [104].
Nowadays, it is difficult to predict the impact that Tissue 
Engineering using tooth stem cells will have in the future. 
However, independently of this doubt, it is possible to conclude the 
great potential of these cells and the wish to use it efficiently. This 
requires better understanding of the mechanisms of self-renewal 
in order to sufficiently regulate adult stem cell growth in vitro (to 
generate required cell numbers needed for different applications); 
the regulation of stem cells during differentiation and maturation 
into tissue-specific cell types, as well as during wound healing; 
the interactions between stem cells and the immune system, 
in particular, regarding use of allogeneic cell populations; and 
mechanisms needed to control and prevent ex vivo-expanded 
mesenchymal stem cells from transformation [105].
Clinical trials previously performed suggest that additional 
information about tooth stem cells and their medical applications 
is essential to understand the therapeutic real efficacy, cell survival, 
integration, functionality and safety in long terms.
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